May 8, 2018 / 10:49 PM / 18 days ago

BRIEF-Xenon Pharmaceuticals Q1 Net Loss Per Common Share $0.21

May 8 (Reuters) - Xenon Pharmaceuticals Inc:

* XENON PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* QTRLY NET LOSS PER COMMON SHARE $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.48 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below